Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-12-12
1998-05-19
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 54, 514711, A61K 3134, A61K 31715, A61K 3110
Patent
active
057536961
ABSTRACT:
Compositions and methods for using the same to restore dehydroepiandrosterone (DHEA) levels in humans are described. Compositions comprising methyl sulfonyl methane and vitamin C, and additionally beta-1,3-glucan, are administered to humans to enhance DHEA levels. The compositions can be taken in various forms, such as a dried powdered mix with liquid, or as a pill, tablet, or capsule.
REFERENCES:
patent: 4518595 (1985-05-01), Coleman et al.
patent: 4774093 (1988-09-01), Provonchee et al.
patent: 4835147 (1989-05-01), Roberts
patent: 5071878 (1991-12-01), Herschler
patent: 5077284 (1991-12-01), Loria et al.
patent: 5110810 (1992-05-01), Eich et al.
patent: 5162198 (1992-11-01), Eich et al.
patent: 5609617 (1997-03-01), Shealy et al.
C. Shealy, et al., "Method for Enhancement of Dehydroepiandrosterone", U.S. Patent Application Ser. No. 09/390,365, filed Mar. 21, 1995.
S. Kent, "DHEA: `Miracle` drug?", Geriatrics for the Primary Care Physician, vol. 37, No. 9, 1982, pp. 157-159.
N. Orentreich, et al., "Age Changes and Sex Differences in Serum Dehydroepiandrosterone Sulfate Concentrations throughout Adulthood", The Journal of Clinical Endocrinology & Metabolism, vol. 59, No. 3, 1984, pp. 551-555.
E. Barrett-Connor, et al., "A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular Disease", The New England Journal of Medicine, vol. 315, No. 24, 1986, pp. 1519-1524.
G.B. Gordon, et al., "Reduction of Atherosclerosis by Administration of Dehydroepiandrosterone", The Journal of Clinical Investigation, vol. 82, No. 2, 1988, pp. 712-720.
W. Regelson, et al., "Hormonal Intervention: `Buffer Hormones` or `State Dependency`", vol. 518, 1988, pp. 260-273.
Y. Arad, et al., "Dehydroepiandrosterone Feeding Prevents Aortic Fatty Streak Formation and Cholesterol Accumulation in Cholesterol-fed Rabbit", Arteriosclerosis, vol. 9, No. 2, 1989, pp. 159-166.
C. Norman Shealy, DHEA: the Youth and Health Hormone, (A Keats Good Health Guide, 1996).
C. Norman Shealy, "A Review of Dehydroepiandrosterone (DHEA)", Integrative Physiological and Behavioral Science, vol. 30, No. 4, 1995, pp. 308-313.
C. Norman Shealy, "DHEA Deficiency in Patients with Chronic Pain and Depression", J. Neurol. Orthop. Med. Surg., vol. 17, 1996, p. 6.
Randall-May Cay
Shealy C. Norman
Cluster Technology Corp.
Henley III Raymond
LandOfFree
Compositions and methods for enhancement of dehydroepiandrostero does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for enhancement of dehydroepiandrostero, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for enhancement of dehydroepiandrostero will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1853549